TSHA Completes Dosing
Taysha Gene Therapies completes dosing in REVEAL pivotal trial and reports longer-term clinical data from Part A of REVEAL Phase 1/2 trials for TSHA-102
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.